Science 37 makes Nasdaq debut

Science 37 makes Nasdaq debut
Science 37 makes Nasdaq debut

Clinical research company Science 37 CEO David Coman joins the Yahoo Finance’s Adam Shapiro to discuss the company’s SPAC debut.

Previous articleMarket Recap: Monday, Oct.11: Stocks close at lows
Next articleSeptember jobs report highlights need for teachers; Ireland signs global tax agreement; and more